companydata.dkcompanydata.dk

KEBOMED A/S: Financial statements 2022

CVR: 28490704

Source: annual report 2022, Danish Business Authority

01/07/2021 – 30/06/2022

KEBOMED A/S (CVR 28490704) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 39,270,176 and a net result of DKK 9,092,584 compared with DKK 12,906,571 the year before. That is a decrease of 5.3% compared with the year before. Equity in the 2022 report amounted to DKK 40,336,942. The solvency ratio was 75.6%. The company had 23 employees in the financial year.

Gross Profit
DKK 39,270,176
Profit/Loss
DKK 9,092,584
Equity
DKK 40,336,942
Total Assets
DKK 53,361,652
Employees
23

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-39.3M9.1M40.3M23
2021-41.5M12.9M31.2M25
2020-39M9M18.3M-
2019-37.8M8.3M9.3M-
2018-41.2M11.6M12.6M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on KEBOMED A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

About KEBOMED A/S

KEBOMED A/S is a Danish company of the type Aktieselskab based in Glostrup, founded in 2005. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named KEBO MED A/S. The management consists of Henrik Schjødt. The board consists of Niels Søren Frederik Kornerup (chair), Henrik Schjødt and Søren Dalmark Kornerup. The company is owned by Kebomed Europe Holding AG. The company has 23 employees (2026). In 2026, the company reported a gross profit of DKK 52,977,983 and a net result of DKK 13,110,236 compared with DKK 9,827,524 the year before. Equity in the 2026 report amounted to DKK 36,352,192.

Source: annual report 2026, Danish Business Authority